Company: RPTX
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0000950170-25-070351
Chunk: 0

Company: Repare Therapeutics Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Item 1
Chunk 0
---
Repare Therapeutics Inc.

Condensed Consolidated Balance Sheets 

(Unaudited) 

(Amounts in thousands of U.S. dollars, except share data) 

     As of March 31,

     As of December 31,

     2025

     2024

     ASSETS

     CURRENT ASSETS:

     Cash and cash equivalents
      
     $
     84,455

     $
     84,717

     Marketable securities

     39,773

     68,074

     Income tax receivable

     9,983

     10,600

     Other current receivables

     1,586

     1,746

     Prepaid expenses

     4,546

     6,012

     Total current assets

     140,343

     171,149

     Property and equipment, net

     1,108

     2,294

     Operating lease right-of-use assets

     1,365

     1,924

     Income tax receivable

     1,207

     960

     Other assets

     —

     179

     TOTAL ASSETS
      
     $
     144,023

     $
     176,506

     LIABILITIES AND SHAREHOLDERS’ EQUITY

     CURRENT LIABILITIES:

     Accounts payable
      
     $
     2,284

     $
     3,623

     Accrued expenses and other current liabilities

     15,270

     19,819

     Operating lease liability, current portion

     1,372

     1,845

     Total current liabilities

     18,926

     25,287

     Operating lease liability, net of current portion

     —

     88

     TOTAL LIABILITIES

     18,926

     25,375

     SHAREHOLDERS’ EQUITY

     Preferred shares, no par value per share; unlimited shares authorized as of   March 31, 2025 and December 31, 2024; 0 shares issued and outstanding   as of March 31, 2025, and December 31, 2024

     —

     —

     Common shares, no par value per share; unlimited shares authorized as of    March 31, 2025 and December 31, 202